IBRX is trading 5% up today at $9.19, extending a strong multi-day rally as investors anticipate potential inclusion in the Russell 1000 index and forthcoming updates on Anktiva's Saudi expansion and Q2 sales.
- Bullish analyst sentiment, with a consensus Strong Buy rating and a $14.20 price target, further fuels speculative momentum.
- The stock's rally is largely driven by these company-specific catalysts rather than broader market movements.